Advertisement
Screener

AbCellera Biologics Inc. (ABCL) ROA

AbCellera Biologics Inc. (ABCL) ROA

  • 2026-06-30: ROA -12.59%.
  • 2026-03-31: ROA -11.01%.
  • 2025-12-31: ROA -10.79%.
  • 2025-09-30: ROA -12.66%.

Complete source-backed roa history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-12.59%
2026-03-31-11.01%
2025-12-31-10.79%
2025-09-30-12.66%
2025-06-30-11.82%
2025-03-31-12.49%
2024-12-31-11.97%
2024-09-30-12.62%
2024-06-30-10.85%
2024-03-31-10.04%
2023-12-31-9.84%
2023-09-30-8.54%
2023-06-30-4.81%
2023-03-31-3.35%
2022-12-3110.29%
2022-09-3016.00%
2022-06-3012.57%
2022-03-3112.86%
2021-12-3111.64%
2021-09-3017.95%
2021-06-3019.90%
2021-03-3121.11%
2020-12-3111.83%

Annual ROA

DateROA
2025-12-31-10.79%
2024-12-31-11.97%
2023-12-31-9.84%
2022-12-3110.29%
2021-12-3111.64%
2020-12-3111.83%

Similar stocks

Stock NameCountryMarket CapPE Ratio
ACADIA PHARMACEUTICALS INC (ACAD)United States$3.823B11.45
Xenon Pharmaceuticals Inc. (XENE)$3.684B-14.27
Tango Therapeutics, Inc. (TNGX)United States$4.154B-42.53
Organon & Co. (OGN)United States$3.603B17.03
IDEAYA Biosciences, Inc. (IDYA)United States$3.540B-20.52
Indivior Pharmaceuticals, Inc. (INDV)$4.250B14.09
Viking Therapeutics, Inc. (VKTX)United States$4.287B-8.51
Amylyx Pharmaceuticals, Inc. (AMLX)United States$3.361B-13.15
Enliven Therapeutics, Inc. (ELVN)United States$3.307B-35.07
Arcutis Biotherapeutics, Inc. (ARQT)United States$3.303B115.47